Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Sep;55(9):785–788. doi: 10.1136/thorax.55.9.785

Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease?

M Thomason 1, D Strachan 1
PMCID: PMC1745857  PMID: 10950899

Abstract

BACKGROUND—Previous epidemiological studies have related mortality from chronic obstructive pulmonary disease (COPD) to forced expiratory volumes (FEV1 or FEV0.75) and it is unknown whether other spirometric indices might have greater predictive power.
METHODS—A case-control study of fatal COPD was conducted within a cohort of London civil servants who performed forced expiratory spirograms in 1967-9 and were followed up for mortality over 20years. The spirograms of 143 men who died of COPD (ICD8 491, 492or 519.8) were compared with those of 143 controls individually matched for age, height, and smoking habit who survived longer than their matched case. Flow rates in different parts of the spirogram were compared within case-control pairs and analysed as predictors of fatal COPD by conditional logistic regression.
RESULTS—Within pair case:control ratios of FEV1, mid expiratory flow rates (e.g. FEF50-75) and FEF75-85 were highly intercorrelated (r>0.7) but correlations with FEF85-95 were weaker (r<0.5). All indices except the FEV1/FVC ratio were stronger predictors of death from COPD within the first 10 years than of later deaths (15-19 years). After adjustment for FEV1, mid expiratory flow rates independently predicted fatal COPD but end expiratory flow rates did not. The FEV1 adjusted mortality ratios associated with a 10% decrement in each index were 2.24 (95% CI 1.54 to 3.76) for FEF50-75, 1.20 (95% CI 1.00 to 1.42) for FEF75-85, and 1.10 (95% CI 0.96 to 1.26) for FEF85-95.
CONCLUSION—This study confirms FEV1 and mid expiratory flow rates as powerful predictors of mortality from COPD, and suggests that measurement of end expiratory flow rates would add little extra predictive information.



Full Text

The Full Text of this article is available as a PDF (122.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annesi I., Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. Am Rev Respir Dis. 1986 Oct;134(4):688–693. doi: 10.1164/arrd.1986.134.4.688. [DOI] [PubMed] [Google Scholar]
  2. Ebi-Kryston K. L. Predicting 15 year chronic bronchitis mortality in the Whitehall Study. J Epidemiol Community Health. 1989 Jun;43(2):168–172. doi: 10.1136/jech.43.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ebi-Kryston K. L. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol. 1988;41(3):251–260. doi: 10.1016/0895-4356(88)90129-1. [DOI] [PubMed] [Google Scholar]
  4. Evans D. J., Green M. Small airways: a time to revisit? Thorax. 1998 Aug;53(8):629–630. doi: 10.1136/thx.53.8.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greaves I. A., Colebatch H. J. Observations on the pathogenesis of chronic airflow obstruction in smokers: implications for the detection of "early" lung disease. Thorax. 1986 Feb;41(2):81–87. doi: 10.1136/thx.41.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hogg J. C., Macklem P. T., Thurlbeck W. M. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968 Jun 20;278(25):1355–1360. doi: 10.1056/NEJM196806202782501. [DOI] [PubMed] [Google Scholar]
  7. Lange P., Nyboe J., Appleyard M., Jensen G., Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax. 1990 Aug;45(8):579–585. doi: 10.1136/thx.45.8.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Macklem P. T. Obstruction in small airways--a challenge to medicine. Am J Med. 1972 Jun;52(6):721–724. doi: 10.1016/0002-9343(72)90077-0. [DOI] [PubMed] [Google Scholar]
  9. Peto R., Speizer F. E., Cochrane A. L., Moore F., Fletcher C. M., Tinker C. M., Higgins I. T., Gray R. G., Richards S. M., Gilliland J. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis. 1983 Sep;128(3):491–500. doi: 10.1164/arrd.1983.128.3.491. [DOI] [PubMed] [Google Scholar]
  10. Reid D. D., Brett G. Z., Hamilton P. J., Jarrett R. J., Keen H., Rose G. Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet. 1974 Mar 23;1(7856):469–473. doi: 10.1016/s0140-6736(74)92783-4. [DOI] [PubMed] [Google Scholar]
  11. Solomon D. A. Are small airways tests helpful in the detection of early airflow obstruction? Chest. 1978 Nov;74(5):567–569. doi: 10.1378/chest.74.5.567. [DOI] [PubMed] [Google Scholar]
  12. Strachan D. P. Ventilatory function as a predictor of fatal stroke. BMJ. 1991 Jan 12;302(6768):84–87. doi: 10.1136/bmj.302.6768.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Strachan D. P. Ventilatory function, height, and mortality among lifelong non-smokers. J Epidemiol Community Health. 1992 Feb;46(1):66–70. doi: 10.1136/jech.46.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wright J. L., Hobson J., Wiggs B. R., Pare P. D., Hogg J. C. Effect of cigarette smoking on structure of the small airways. Lung. 1987;165(2):91–100. doi: 10.1007/BF02714426. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES